We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+11.16%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$294M
AUM Growth
+$47M
Cap. Flow
+$52.7M
Cap. Flow %
17.92%
Top 10 Hldgs %
26.72%
Holding
84
New
21
Increased
28
Reduced
22
Closed
9

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$5.68M
2
GILD icon
Gilead Sciences
GILD
+$5.11M
3
AET
Aetna Inc
AET
+$4.9M
4
BSX icon
Boston Scientific
BSX
+$4.74M
5
KND
Kindred Healthcare
KND
+$3.25M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$6.31M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$6.08M
3
SYK icon
Stryker
SYK
+$5.14M
4
LPNT
LifePoint Health, Inc.
LPNT
+$3.19M
5
AMGN icon
Amgen
AMGN
+$3.1M

Sector Composition

Rank Sector Weight
1 Healthcare 84.8%
2 Financials 1.81%
3 Industrials 0.84%
4 Energy 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMN icon
51
AMN Healthcare
AMN
$1.28B
$2.65M 0.9%
115,000
-21,600
-16% -$447K
RVTY icon
52
Revvity
RVTY
$12.9B
$2.56M 0.87%
+50,000
New +$2.32M
VWR
53
DELISTED
VWR Corporation
VWR
$2.47M 0.84%
95,000
+20,600
+28% +$513K
AVNS
54
DELISTED
Avanos Medical
AVNS
$2.46M 0.84%
+50,000
New +$2.32M
HRC
55
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.35M 0.8%
48,020
-20,680
-30% -$985K
ABT icon
56
Abbott
ABT
$190B
$2.32M 0.79%
+50,000
New +$2.3M
ZTS icon
57
Zoetis
ZTS
$31.1B
$2.31M 0.79%
50,000
-19,400
-28% -$875K
HSP
58
DELISTED
HOSPIRA INC
HSP
$2.31M 0.79%
26,300
-33,200
-56% -$2.6M
LHCG
59
DELISTED
LHC Group LLC
LHCG
$2.3M 0.78%
69,500
+10,000
+17% +$312K
ESRX
60
DELISTED
Express Scripts Holding Company
ESRX
$2.17M 0.74%
25,000
-21,666
-46% -$1.82M
CCRN
61
DELISTED
Cross Country Healthcare
CCRN
$1.96M 0.67%
165,000
+16,700
+11% +$191K
ALGN icon
62
Align Technology
ALGN
$12.3B
$1.88M 0.64%
+35,000
New +$1.99M
IPXL
63
DELISTED
Impax Laboratories, Inc.
IPXL
$1.88M 0.64%
40,000
-9,600
-19% -$382K
CPHD
64
DELISTED
Cepheid Inc
CPHD
$1.87M 0.64%
+32,843
New +$1.85M
STE icon
65
Steris
STE
$23.2B
$1.78M 0.61%
25,367
– –
MNTA
66
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.52M 0.52%
+100,000
New +$1.3M
UAM
67
DELISTED
Universal American Corp
UAM
$1.5M 0.51%
140,000
-157,400
-53% -$1.48M
AKRX
68
DELISTED
Akorn Inc
AKRX
$1.43M 0.48%
+30,000
New +$1.36M
JUNO
69
DELISTED
Juno Therapeutics, Inc.
JUNO
$1.21M 0.41%
+20,000
New +$971K
NXTM
70
DELISTED
NxStage Medical Inc.
NXTM
$1.21M 0.41%
70,000
-29,700
-30% -$525K
IRWD icon
71
Ironwood Pharmaceuticals
IRWD
$711M
$1.2M 0.41%
+89,550
New +$1.17M
ACAD icon
72
Acadia Pharmaceuticals
ACAD
$5.07B
$1.14M 0.39%
+35,000
New +$1.2M
BLUE
73
DELISTED
bluebird bio
BLUE
$1.09M 0.37%
+695
New +$917K
PTLA
74
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$949K 0.32%
+25,000
New +$859K
SPY icon
75
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$563K 0.19%
+150,000
New +$31M
1 2
3
4

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q1 2015 Portfolio in Review

As of Q1 2015, Sivik Global Healthcare held 84 positions worth $294M, up 19% from $247M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Sivik Global Healthcare deployed $52.7M of net new capital in Q1 2015, opening 21 new positions and adding to 28 existing holdings. Its largest new stake was Medtronic: 75,000 shares worth $5.85M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 90% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Amgen, an estimated $3.1M trimmed.

  • Sivik Global Healthcare's largest Q1 2015 buy was Medtronic: 75,000 shares worth $5.85M.
  • Sivik Global Healthcare added most to Gilead Sciences in Q1 2015, an estimated $5.11M increase.
  • Sivik Global Healthcare's biggest Q1 2015 reduction was Amgen, cutting an estimated $3.1M.
  • Sivik Global Healthcare fully exited Allergan Inc in Q1 2015, selling an estimated $6.31M.
  • Sivik Global Healthcare's ten largest holdings make up 27% of its $294M portfolio in Q1 2015.
  • Sivik Global Healthcare opened 21 new positions and closed 9 in Q1 2015.
  • Sivik Global Healthcare's portfolio value rose 19% quarter-over-quarter to $294M.

Based on Sivik Global Healthcare's 13F filing for Q1 2015, filed 1 Apr 2015.